Nationwide Fund Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-24,500
Closed -$3.58M 1051
2017
Q3
$3.58M Buy
24,500
+3,500
+17% +$512K 0.01% 1171
2017
Q2
$3.27M Buy
21,000
+9,750
+87% +$1.52M 0.01% 1215
2017
Q1
$1.63M Sell
11,250
-11,250
-50% -$1.63M 0.01% 1500
2016
Q4
$2.45M Sell
22,500
-65,720
-74% -$7.16M 0.01% 1320
2016
Q3
$10.7M Sell
88,220
-58,810
-40% -$7.14M 0.04% 579
2016
Q2
$20.8M Buy
147,030
+126,432
+614% +$17.9M 0.09% 261
2016
Q1
$2.69M Buy
20,598
+4,266
+26% +$557K 0.01% 1213
2015
Q4
$2.3M Sell
16,332
-8,126
-33% -$1.14M 0.01% 1304
2015
Q3
$3.25M Sell
24,458
-24,481
-50% -$3.25M 0.01% 1131
2015
Q2
$8.62M Sell
48,939
-31,960
-40% -$5.63M 0.04% 657
2015
Q1
$14M Buy
80,899
+22,942
+40% +$3.96M 0.06% 437
2014
Q4
$9.49M Buy
57,957
+2,557
+5% +$419K 0.04% 580
2014
Q3
$8.9M Buy
55,400
+5,900
+12% +$947K 0.04% 621
2014
Q2
$7.28M Sell
49,500
-33,416
-40% -$4.91M 0.03% 760
2014
Q1
$11.5M Buy
82,916
+48,690
+142% +$6.75M 0.05% 442
2013
Q4
$4.33M Sell
34,226
-16,310
-32% -$2.06M 0.02% 1030
2013
Q3
$4.65M Buy
50,536
+10,920
+28% +$1M 0.02% 948
2013
Q2
$2.72M Buy
+39,616
New +$2.72M 0.01% 1127